Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention?
Saved in:
| Title: | Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention? |
|---|---|
| Authors: | Sánchez-Quesada JL; Cardiovascular Biochemistry, Institut de Recerca Sant Pau (IR Sant Pau), Barcelona, Spain.; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain., Pérez A; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain.; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Apr 27; Vol. 17, pp. 1813342. Date of Electronic Publication: 2026 Apr 27 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2026.1813342 |
